Opioid Use Disorder clinical trials

Explore recruiting opioid use disorder clinical trials.

Recruiting opioid use disorder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Opioid Use Disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase IV Longitudinal Study of SUBLOCADE (SUBUTEX Prolonged Release) Clinical Outcomes in Adults with Opioid Use Disorder (Opioid Dependence)

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy of Ketamine for the Prevention of Relapse in Patients with Opioid-Use Disorders (OUD)

Cyprus

Therapeutic exploratory (Phase II) EU CTIS Study details

The dual orexin receptor antagonist daridorexant as an adjunct to improve buprenorphine maintenance therapy of opioid use disorder

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Single-Blind, Fixed-Order Crossover Study to Assess the Effects of CSX-1004 Injection on Fentanyl-Induced Respiratory Depression in Healthy Adult Subjects and Subjects with Opioid Use Disorder

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

(ROAR) Reversal of opioid-induced respiratory depression with opioid antagonists - a pharmacokinetic pharmacodynamic modeling study in opioid naïve individuals and chronic opioid users under real-life conditions

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Oral rifaximin in patients with opioid use disorder (OUD): multicenter clinical trial on the microbiota–gut–brain axis

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Opioid Use Disorder trials by city

Opioid Use Disorder in Toronto Opioid Use Disorder in Vancouver Opioid Use Disorder in Montreal Opioid Use Disorder in Calgary Opioid Use Disorder in Edmonton Opioid Use Disorder in Ottawa Opioid Use Disorder in Winnipeg Opioid Use Disorder in Quebec City Opioid Use Disorder in Hamilton Opioid Use Disorder in Kitchener Opioid Use Disorder in London Opioid Use Disorder in Halifax Opioid Use Disorder in New York Opioid Use Disorder in Los Angeles Opioid Use Disorder in Chicago Opioid Use Disorder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease